GENELUX Corp GNLX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-01-26
GENELUX Corp insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Pulisic Matthew | Chief Financial Officer | 2026-06-16 | Grant | 278,906 | — |
| Groen Eric | General Counsel | 2026-06-16 | Grant | 233,957 | — |
| Cappello Joseph | Chief Technical Officer | 2026-06-16 | Grant | 174,841 | — |
| Tyree James L | director | 2026-06-16 | Grant | 28,409 | — |
| Zindrick Thomas | President and CEO | 2026-06-16 | Grant | 730,601 | — |
| Thomas John | director | 2026-06-16 | Grant | 28,409 | — |
| Mirabelli Mary | director | 2026-06-16 | Grant | 28,409 | — |
| Yu Yong | Chief Scientific Officer | 2026-06-16 | Grant | 119,318 | — |
Source: SEC EDGAR filings · CIK 0001231457 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.